Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance

BMC Medical Genomics

Volumn 5, Issue , 2012, Pages

  Lautner Csorba, Orsolya ^a   Gézsi, András ^a   Semsei, Ágnes F ^a   Antal, Péter ^b   Erdélyi, Dániel J ^c   Schermann, Géza ^a   Kutszegi, Nóra ^a   Csordás, Katalin ^c   Hegyi, Márta ^c   Kovács, Gábor ^c   Falus, András ^a   Szalai, Csaba ^a,d,e  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d HEIM PÁL CHILDREN S HOSPITAL   (Hungary)

^e Csertex Research Laboratory   (Hungary)

Author keywords

ALL susceptibility; Bayesian network based Bayesian multilevel analysis of relevance (BN BMLA); Direct and indirect interactions; Frequentist based statistical analysis; Gene gene interaction; Genetics; Genomics; Risk factors; Strong relevance; Systems biology; Transitive interaction

Indexed keywords

NOTCH1 RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; STAT1 PROTEIN; STAT3 PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARID5B GENE; ARTICLE; BAX GENE; BAYES THEOREM; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CEBPA GENE; CHILD; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; IKZF1 GENE; MAJOR CLINICAL STUDY; MALE; NOTCH1 GENE; PRIORITY JOURNAL; PROTO ONCOGENE; RISK FACTOR; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; STAT1 GENE; STAT3 GENE;

ADOLESCENT; BAYES THEOREM; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INFANT; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MULTILEVEL ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 84866679598     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-5-42     Document Type: Article

References (38)

1. Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemia. Sherborne AL, Hemminki K, Kumar R, Bartram CR, Stanulla M, Schrappe M, Petridou E, Semsei AF, Szalai C, Sinnett D, et al. Haematologica 2011 96 7 1049 1054 10.3324/haematol.2011. 040121 21459794
2. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Sherborne AL, Hosking FJ, Prasad RB, Kumar R, Koehler R, Vijayakrishnan J, Papaemmanuil E, Bartram CR, Stanulla M, Schrappe M, et al. Nat Genet 2010 42 6 492 494 10.1038/ng.585 20453839
3. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Treviño LR, Yang W, French D, Hunger SP, Carroll WL, Devidas M, Willman C, Neale G, Downing J, Raimondi SC, et al. Nat Genet 2009 41 9 1001 1005 10.1038/ng.432 19684603
4. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, Price A, Olver B, Sheridan E, Kinsey SE, Lightfoot T, Roman E, Irving JAE, et al. Nat Genet 2009 41 9 1006 1010 10.1038/ng.430 19684604
5. Association of some rare haplotypes and genotype combinations in the MDR1 gene with childhood acute lymphoblastic leukaemia. Semsei AF, Erdélyi DJ, Ungvári I, Kámory E, Csókay B, Andrikovics H, Tordai A, Cságoly E, Falus A, Kovács GT, et al. Leuk Res 2008 32 8 1214 1220 10.1016/j.leukres.2007.12.009 18243305
6. Replication analysis confirms the association of ARID5B with childhood B-cell acute lymphoblastic leukemia. Healy J, Richer C, Bourgey M, Kritikou EA, Sinnett D, Haematologica 2010 95 9 1608 1611 10.3324/haematol.2010.022459 20460642
7. Bioinformatics challenges for genome-wide association studies. Moore JH, Asselbergs FW, Williams SM, Bioinformatics 2010 26 4 445 455 10.1093/bioinformatics/btp713 20053841
8. Strengths and weaknesses of gene association studies in childhood acute lymphoblastic leukemia. Semsei AF, Antal P, Szalai C, Leuk Res 2010 34 3 269 271 10.1016/j.leukres.2009.07.036 19716175
9. Learning complex bayesian network features for classification. Antal P, Hullam G, Gezsi A, Millinghoffer A, Proceeding of third European Workshop on Probabilistic Graphical Models: 2006 Prague: Czech Republic 2006 9 16
10. A Bayesian view of challenges in feature selection: feature aggregation, multiple targets, redundancy and interaction. Antal P, Millinghoffer A, Hullam G, Szalai C, Falus A, JMLR Workshop and Conference Proceedings: New challenges for feature selection in data mining and knowledge discovery: 2008 Belgium: Antwerpen 2008 74 89
11. A bioinformatic platform for a Bayesian, multiphased, multilevel analysis in immunogenomics. Antal P, Millinghoffer A, Hullám G, Hajós G, Szalai C, Falus A, Bioinformatics for Immunomics, Immunomics reviews New York, USA: Springer, Flower D, Davies M, Ranganathan S, 3 2010 157 185
12. Evaluation of a Bayesian model-based approach in GA studies. Hullam G, Antal P, Szalai C, Falus A, Proceedings of the third International Workshop on Machine Learning in Systems Biology: 2010 Slovenia: Ljubljana 2010 30 43
13. Evaluation of a partial genome screening of two asthma susceptibility regions using Bayesian network based Bayesian multilevel analysis of relevance. Ungvári I, Hullám G, Antal P, Kiszel P, Gézsi A, Hadadi É Virág V, Hajós G, Millinghoffer A, Nagy A, et al. PLoS One 2012 7 3 33573 10.1371/journal.pone.0033573 22432035
14. International HapMap Project-HapMap Database http://www.hapmap.org.
15. Tests for deviation from Hardy-Weinberg equilibrium and tests for association http://ihg2.helmholtz-muenchen.de/cgi-bin/hw/hwa1.pl.
16. A Bayesian method for the induction of probabilistic networks from data. Cooper GF, Herskovits E, Mach Learn 1992 9 4 309 347
17. Parallel Metropolis coupled Markov chain Monte Carlo for Bayesian phylogenetic inference. Altekar G, Dwarkadas S, Huelsenbeck JP, Ronquist F, Bioinformatics 2004 20 3 407 415 10.1093/bioinformatics/btg427 14960467 (Pubitemid 38262773)
18. Gelman A, Carlin JB, Stern HS, Rubin DB, Dunson DB, Bayesian Data Analysis London: Chapman & Hall 3 1995
19. Gamerman D, Markov Chain Monte Carlo London: Chapman and Hall 1997
20. Gene targeting of Desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs. Lahoud MH, Ristevski S, Venter DJ, Jermiin LS, Bertoncello I, Zavarsek S, Hasthorpe S, Drago J, de Kretser D, Hertzog PJ, et al. Genome Res 2001 11 8 1327 1334 10.1101/gr.168801 11483573 (Pubitemid 32771539)
21. Genome-wide association study of childhood acute lymphoblastic leukemia in Korea. Han S, Lee KM, Park SK, Lee JE, Ahn HS, Shin HY, Kang HJ, Koo HH, Seo JJ, Choi JE, et al. Leuk Res 2010 34 10 1271 1274 10.1016/j.leukres.2010.02.001 20189245
22. The Ikaros gene encodes a family of lymphocyte-restricted zinc finger DNA binding proteins, highly conserved in human and mouse. Molnár A, Wu P, Largespada DA, Vortkamp A, Scherer S, Copeland NG, Jenkins NA, Bruns G, Georgopoulos K, J Immunol 1996 156 2 585 592 8543809 (Pubitemid 26028917)
23. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J, White D, Hughes TP, Le Beau MM, Pui CH, et al. Nature 2008 453 7191 110 114 10.1038/nature06866 18408710 (Pubitemid 351630327)
24. Cutting edge: inherent and acquired resistance to radiation-induced apoptosis in B cells: a pivotal role for STAT3. Otero DC, Poli V, David M, Rickert RC, J Immunol 2006 177 10 6593 6597 17082570 (Pubitemid 44715021)
25. Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. Haga S, Terui K, Zhang HQ, Enosawa S, Ogawa W, Inoue H, Okuyama T, Takeda K, Akira S, Ogino T, et al. J Clin Invest 2003 112 7 989 998 14523036 (Pubitemid 38056314)
26. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Grandis JR, Drenning SD, Zeng Q, Watkins SC, Melhem MF, Endo S, Johnson DE, Huang L, He Y, Kim JD, Proc Natl Acad Sci U S A 2000 97 8 4227 4232 10.1073/pnas.97.8.4227 10760290 (Pubitemid 30226115)
27. STAT3 is a substrate of SYK tyrosine kinase in B-lineage leukemia/lymphoma cells exposed to oxidative stress. Uckun FM, Qazi S, Ma H, Tuel-Ahlgren L, Ozer Z, Proc Natl Acad Sci U S A 2010 107 7 2902 2907 10.1073/pnas.0909086107 20133729
28. Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph). Butterbach K, Beckmann L, de Sanjose S, Benavente Y, Becker N, Foretova L, Maynadie M, Cocco P, Staines A, Boffetta P, et al. Br J Haematol 2011 153 3 318 333 10.1111/j.1365-2141.2011. 08632.x 21418178
29. STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma. Ito N, Eto M, Nakamura E, Takahashi A, Tsukamoto T, Toma H, Nakazawa H, Hirao Y, Uemura H, Kagawa S, et al. J Clin Oncol 2007 25 19 2785 2791 10.1200/JCO.2006.09.8897 17602083 (Pubitemid 47123187)
30. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Prasad RB, Hosking FJ, Vijayakrishnan J, Papaemmanuil E, Koehler R, Greaves M, Sheridan E, Gast A, Kinsey SE, Lightfoot T, et al. Blood 2010 115 9 1765 1767 10.1182/blood-2009-09-241513 20042726
31. Expression of Stat3 and Notch1 is associated with cisplatin resistance in head and neck squamous cell carcinoma. Gu F, Ma Y, Zhang Z, Zhao J, Kobayashi H, Zhang L, Fu L, Oncol Rep 2010 23 3 671 676 20127005
32. Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Kamakura S, Oishi K, Yoshimatsu T, Nakafuku M, Masuyama N, Gotoh Y, Nat Cell Biol 2004 6 6 547 554 10.1038/ncb1138 15156153 (Pubitemid 38786598)
33. NOTCH1-induced T-cell leukemia in transgenic zebrafish. Chen J, Jette C, Kanki JP, Aster JC, Look AT, Griffin JD, Leukemia 2007 21 3 462 471 10.1038/sj.leu.2404546 17252014
34. The role of BCL2 family of apoptosis regulator proteins in acute and chronic leukemias. Tzifi F, Economopoulou C, Gourgiotis D, Ardavanis A, Papageorgiou S, Scorilas A, Adv Hematol 2012 2012 524308 21941553
35. Increased BAX expression is associated with an increased risk of relapse in childhood acute lymphocytic leukemia. Hogarth LA, Hall AG, Blood 1999 93 8 2671 2678 10194447 (Pubitemid 29181200)
36. Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo. Prokop A, Wieder T, Sturm I, Essmann F, Seeger K, Wuchter C, Ludwig WD, Henze G, Dorken B, Daniel PT, Leukemia 2000 14 9 1606 1613 10.1038/sj.leu. 2401866 10995007
37. Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA). Preudhomme C, Sagot C, Boissel N, Cayuela JM, Tigaud I, de Botton S, Thomas X, Raffoux E, Lamandin C, Castaigne S, et al. Blood 2002 100 8 2717 2723 10.1182/blood-2002-03-0990 12351377
38. Genagrid Homepage http://redmine.genagrid.eu/projects/bayeseyedownload/ wiki.